Lower solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as Dr. Justine Werbrouck has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Micro
5 to 10 years old
solvency under 10%
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for Dr. Justine Werbrouck. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0672430328
Registered office moved within Kortrijk
The registered office moved from Watertorenhoek 15, 8500 Kortrijk to Leonard Vandorpestraat 22, 8500 Kortrijk · Board meeting of 03-11-2023 · Gazette deed
Company renamed to DR. JUSTINE WERBROUCK
“tekst zoals hierna opgenomen in negende besluit onder titel voorwerp” (deed in Dutch) · Name after signing inVisible after signing in holds all the shares · General meeting of 01-10-2021 · Gazette deed
Registered office moved within Kortrijk
The registered office moved from Sint-Sebastiaanslaan 78, 8500 Kortrijk, België to Watertorenhoek 15, 8500 Kortrijk · Board meeting of 03-07-2019 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Dr. Justine Werbrouck: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €182,000 and €338,000, founded between 2014 and 2019.
What is the company number of Dr. Justine Werbrouck?
The company number of Dr. Justine Werbrouck is 0672.430.328. The VAT number is the same number with BE in front: BE 0672.430.328.
Where is Dr. Justine Werbrouck based?
The registered office is at Leonard Vandorpestraat 22, 8500 Kortrijk.Company details
What does Dr. Justine Werbrouck do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of Dr. Justine Werbrouck?
Dr. Justine Werbrouck is a private limited company (BV).
When was Dr. Justine Werbrouck founded?
Dr. Justine Werbrouck was founded on 06-03-2017.
Is Dr. Justine Werbrouck still active?
Yes, Dr. Justine Werbrouck is an active enterprise in the KBO register.
How many employees does Dr. Justine Werbrouck have?
Dr. Justine Werbrouck had an average of 0.5 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
Which joint committee does Dr. Justine Werbrouck fall under?
In its 2021 annual accounts, Dr. Justine Werbrouck states joint committee 330 (Health institutions and services).
What is the turnover of Dr. Justine Werbrouck?
The turnover in financial year 2025 is about €340,000. This figure is estimated from the gross margin of €172,685 and 84 comparable companies (NACE 86). It probably lies between €260,000 and €430,000.
Is Dr. Justine Werbrouck profitable?
In financial year 2025, Dr. Justine Werbrouck made a profit of €113,203.
Where can I find the annual accounts of Dr. Justine Werbrouck?
Dr. Justine Werbrouck filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Justine Werbrouck due?
Dr. Justine Werbrouck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline